Summary |
|
||||||||||
Variant origin |
|
||||||||||
Variant description |
|
||||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:56630DBA/2J and C57BL/6J mice exhibit differential sensitivity to seizure induced by pentylenetetrazol (PTZ) with DBA/2J mice being sensitive and C57BL/6J mice being relatively resistant. PTZ-induced seizure responses were studied in DBA/2J, C57BL/6J, (DBA/2Jx C57BL/6J)F1 and (DBA/2J x C57BL/6J)F2 intercross mice. QTL mapping and complementary statistical analysis identified loci on proximal (near D1Mit11) and distal (near D1Mit17) Chromosome 1. The peak LOD score on Chromosome 1 was associated with more distal markers D1Mit30 and D1Mit16 (LOD = 12.7 with 14.7% of total variance explained). The location of the peak coincides closely with the peak seen in a previously reported study (J:38888) of kainic acid-induced seizures in these strains of mice. The locus was assigned as Szs1. Candidate genes in this region include Atp1a2, Atp1b1 and Kcnj10. A second peak was detected more proximally, near markers D1Mit7 and D1Mit11 (LOD = 10.3 with 11.6% of total variance explained). This locus was designated as seizure susceptibility 5 (Szs5). A relevant candidate gene near this locus is Slc4a3. Both Szs1 and Szs5 are derived from DBA/2J-derived susceptibility alleles. |
||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/05/2024 MGI 6.24 |
|
|